Study Nurses Chantal Fischer Study Nurse 0511-532-8333 fischer.chantal @ mh-hannover.de Manuela Geyer Study Nurse 0511-532-3116 geyer.manuela @ mh-hannover.de Sikinika Hache Study Nurse 0511-532-3118 hache [...] hache.sikinika @ mh-hannover.de Heike Jahnke Study Nurse 0511-532-3575 jahnke.heike @ mh-hannover.de Michaela Ivana Schwippert Study Nurse schwippert.michaela @ mh-hannover.de
qualitative study Lotte Katrijn ten Brinke: Perinatal grief intensity of bereaved mothers during the COVID-19 pandemic in Germany and Austria: based on results from the cross-sectional COCOON study 2024 Anita [...] Anita Kusi Appiah: An explorative qualitative study on the experiences of first-time mothers on the duration of breastfeeding Anna Bottani: A qualitative study of obstetric violence in Western Switzerland [...] pandemic in Austria: a cross-sectional study Anthonia (Tessa) Laros: Midwives’ experiences with applying perinatal guidelines during shared decision-making: a qualitative study Kelly Schoonbaert: Risk factors
Immunosuppression. Study Phase: 3b – (three renal transplant centres Clinical Protocol: HGS1006-C1121 (Human Genome Sciences): A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the [...] Phase 2 Study Evaluation of the efficacy and safety of Anifrolumab in adult subjects with active proliferative Lupus nephritis ALE.F02.03A Randomized, Double-Blind, Placebo-Controlled Study of Intravenously [...] Clinical Protocol: 3xBIOS² study: Biomarkers of renal graft injuries in kidney allograft recipients (BIOMARGIN) CCFZ533X2201: A 12-months randomized, multiple dose, open-label, study evaluating safety, tolerability
schreiben Sie uns. Aktuelle klinische Studien Alpha-1-Antitrypsin-Mangel (AATM) PPRO024-001_Sunshine- Study Diese Phase III Studie beschäftigt sich mit der Sicherheit und der Bewertung klinischer Parameter [...] tik durchgeführt. (EU CT No. 2024-512113-41-00) AR-DEX-22-02_EXHALE-3 https://clinicaltrials.gov/study/NCT05813288 Phase 3, Eine randomisierte, placebokontrollierte Doppelblindstudie im Parallelgruppendesign [...] n in den letzten 12 Monaten. (EudraCT: 2023-503693-20) INCB 54707-208 https://clinicaltrials.gov/study/NCT05851443 Eine Placebo- kontrollierte Phase 2 Studie zur Wirksamkeit und Sicherheit von oralem
Leitende Studienassistentin (Study Nurse) Telefon: +49 (0) 511 5350-8320 E-Mail: Galetzka.Carola @ mh-hannover.de Gesine Müller-Schöner Stellv. leitende Studienassistentin (Study Nurse) Telefon: +49 (0) 511 [...] .de Franziska Domke Studienassistentin (Study Nurse) Telefon: +49 (0) 511 5350-8347 E-Mail: Domke.Franziska @ mh-hannover.de Özcan Balik Studienassistent (Study Nurse) Telefon: +49 (0) 511 5350-8321 E-Mail: [...] ECTU - Team die wissenschaftliche Projektleitung mit hochqualifiziertem Studienpersonal (Prüfärzte, Study Nurses, Dokumentare) auch bei der Planung und Durchführung aller operativen, medizinischen und wi
Bevacizumab versus trans arterial Chemoembolization (TACE) in intermediate-stage HCC IMMUWIN A phase II study of immunotherapy with Durvalumab (MEDI4736) and Tremelimumab in combination with either Y-90 SIRT [...] R0/R1 reseziert Erstlinientherapie MOUNTAINEER-03 (SGNTUC-029) An open label Randomized Phase 3 Study of Tucatinib in Combination with Trastuzumab and mFOLFOX6 versus mFOLFOX6 given with or without either [...] with HER2+ Metastatic Colorectal cancer Gallengangs- bzw. Cholangiokarzinom Lokal IMMUWHY A phase II study of immunotherapy with durvalumab (MEDI4736) or durvalumab and tremelimumab, both combined with Y-90
better tolerated drug. This study is funded by Emalex Biosciences, Inc. and is currently being conducted in numerous countries and centers worldwide. Study participation: This study is open to children and [...] National Institute of Mental Health (NIMH): 1R01MH115958-01 Participation in the study: Only “children” can participate in this study together with their parents (so-called "parent-child trios"). The child must [...] Participation in the study is therefore no longer possible. Resulting publications: Jakubovski E, Reichert C, Karch A, Buddensiek N, Breuer D, Müller-Vahl K. The ONLINE-TICS Study Protocol: A Randomized
Klinische Studien Saskia Schock Head Study Nurse/Hauttumorzentrum 0511 532 7678 Marcel Schock Studienkoordinator/Hauttumorzentrum 0511 532 7662 Olga Dell Study Nurse/Experimentelle Forschung 0511 532 5086 [...] 532 7663 Joëlle Naim, M.A. wissenschaftliche Mitarbeiterin/Experimentelle Forschung Chris Werner Study Nurse/Experimentelle Forschung
chemotherapy. Our study has been published in Breast Cancer Research . breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-025-01960-8 (Feb 2025) Together with the West German Study Group (WSG) [...] carcinoma with and without LCIS . The results of this study indicate the presence of an LCIS component is a good prognostic marker. The results of this study have been published in the European Journal of Cancer [...] (Sept 2023) Together with the West German Study Group (WSG), our group has reported on the WSG-TP-II trial (HR-positive/HER2-positive breast cancer). This study has been published in JAMA Oncology . pubmed
AXSANA / EUBREAST 3 AXillary Surgery After NeoAdjuvant Treatment) A prospective multicenter cohort study to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary [...] Park-Simon / Frau Slobodianiouk CAPItello-292 / D361DC00001 A Phase Ib/III, Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in [...] führung: Prof. Park-Simon / Frau Zarwari ELECTRA / ELA-0121 An Open-label Multicenter Phase 1b-2 Study of Elacestrant in Combination with Abemaciclib in Women and Men with Brain Metastasis from Estrogen